Kranse R - Search Results

1

Serendipity in detecting disease in low prostate-specific antigen ranges.

Vis AN, Kranse R, Roobol M, van der Kwast TH, Schröder FH. Vis AN, et al. Among authors: kranse r. BJU Int. 2002 Mar;89(4):384-9. doi: 10.1046/j.1464-4096.2001.01868.x. BJU Int. 2002. PMID: 11872029 Clinical Trial.

2

The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.

Bangma CH, Kranse R, Blijenberg BG, Schröder FH. Bangma CH, et al. Among authors: kranse r. Urology. 1995 Dec;46(6):773-8. doi: 10.1016/S0090-4295(99)80342-2. Urology. 1995. PMID: 7502414

3

The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.

Bangma CH, Kranse R, Blijenberg BG, Schröder FH. Bangma CH, et al. Among authors: kranse r. Urology. 1995 Dec;46(6):779-84. doi: 10.1016/S0090-4295(99)80343-4. Urology. 1995. PMID: 7502415

4

Some analytical considerations on the measurement of prostate-specific antigen.

Blijenberg BG, Kranse R, Eman I, Schröder FH. Blijenberg BG, et al. Among authors: kranse r. Eur J Clin Chem Clin Biochem. 1996 Oct;34(10):817-21. doi: 10.1515/cclm.1996.34.10.817. Eur J Clin Chem Clin Biochem. 1996. PMID: 8933105

5

The free-to-total serum prostate specific antigen ratio for staging prostate carcinoma.

Bangma CH, Kranse R, Blijenberg BG, Schröder FH. Bangma CH, et al. Among authors: kranse r. J Urol. 1997 Feb;157(2):544-7. J Urol. 1997. PMID: 8996352

6

Analytical evaluation of the new Prostatus PSA Free/Total assay for prostate-specific antigen as part of a screening study for prostate cancer.

Blijenberg BG, Bangma CH, Kranse R, Eman I, Schröder FH. Blijenberg BG, et al. Among authors: kranse r. Eur J Clin Chem Clin Biochem. 1997 Feb;35(2):111-4. Eur J Clin Chem Clin Biochem. 1997. PMID: 9056753 Clinical Trial.

7

Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection.

Rietbergen JB, Kranse R, Kirkels WJ, De Koning HJ, Schröder FH. Rietbergen JB, et al. Among authors: kranse r. Br J Urol. 1997 Apr;79 Suppl 2:57-63. doi: 10.1111/j.1464-410x.1997.tb16922.x. Br J Urol. 1997. PMID: 9126071 Clinical Trial. No abstract available.

8

The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population.

Bangma CH, Rietbergen JB, Kranse R, Blijenberg BG, Petterson K, Schröder FH. Bangma CH, et al. Among authors: kranse r. J Urol. 1997 Jun;157(6):2191-6. J Urol. 1997. PMID: 9146612 Clinical Trial.

9

Free and total prostate-specific antigen in a screened population.

Bangma CH, Kranse R, Blijenberg BG, Schröder FH. Bangma CH, et al. Among authors: kranse r. Br J Urol. 1997 May;79(5):756-62. doi: 10.1046/j.1464-410x.1997.00130.x. Br J Urol. 1997. PMID: 9158515

10

Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer.

Hoedemaeker RF, Rietbergen JB, Kranse R, van der Kwast TH, Schröder FH. Hoedemaeker RF, et al. Among authors: kranse r. World J Urol. 1997;15(6):339-45. doi: 10.1007/BF01300181. World J Urol. 1997. PMID: 9436283 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters